Sabzevari Helen — SEC insider filings

SEC reporting owner CIK 1724195. 37 insider filings on record with FilingPulse; latest filed 2026-08-25.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2021-01-05 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PRECIGEN, INC. (PGEN)President and CEO331 leg · 22,857 sh · $40,00015 legs · 1,216,320 sh · $5,980,43360
Kinnate Biopharma Inc. (KNTE)Director4——6

Insider filings — Sabzevari Helen

FiledFormIssuerReported transactionsSource
2026-08-254PRECIGEN, INC. (PGEN)Option exercise (M): 20,833 · Tax withholding (F): 10,184 @ $7.20 · Option exercise (M): 20,833 (derivative) @ $0EDGAR
2026-07-014PRECIGEN, INC. (PGEN)Option exercise (M): 346,836 @ $2.33 · Sale (S): 346,836 @ $5.89 · Option exercise (M): 346,836 (derivative) @ $0EDGAR
2026-06-014PRECIGEN, INC. (PGEN)Sale (S): 119,250 @ $4.36EDGAR
2026-05-274PRECIGEN, INC. (PGEN)Option exercise (M): 250,000 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2026-04-224PRECIGEN, INC. (PGEN)Grant/award (A): 1,366,000 (derivative) @ $0 · Grant/award (A): 410,000 (derivative) @ $0EDGAR
2026-03-204PRECIGEN, INC. (PGEN)Option exercise (M): 321,100 · Grant/award (A): 321,100 (derivative) @ $0 · Option exercise (M): 321,100 (derivative) @ $0EDGAR
2025-09-164PRECIGEN, INC. (PGEN)Grant/award (A): 825,000 (derivative) @ $0EDGAR
2025-06-274PRECIGEN, INC. (PGEN)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2025-05-274PRECIGEN, INC. (PGEN)Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-05-164PRECIGEN, INC. (PGEN)Option exercise (M): 1,079,137 · Tax withholding (F): 521,224 @ $1.45 · Option exercise (M): 1,079,137 (derivative) @ $0EDGAR
2025-04-184PRECIGEN, INC. (PGEN)Grant/award (A): 1,079,137 (derivative) @ $0EDGAR
2025-02-034PRECIGEN, INC. (PGEN)Grant/award (A): 825,000 @ $0 · Tax withholding (F): 286,967 @ $1.30EDGAR
2024-05-314PRECIGEN, INC. (PGEN)Grant/award (A): 1,803,000 (derivative) @ $0EDGAR
2024-04-094PRECIGEN, INC. (PGEN)Option exercise (M): 1,071,429 · Tax withholding (F): 410,357 @ $1.40 · Grant/award (A): 1,071,429 (derivative) @ $0 · Option exercise (M): 1,071,429 (derivative) @ $0EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)Disposition to issuer (D): 40,501 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 20,250 (derivative)EDGAR
2023-08-254PRECIGEN, INC. (PGEN)Option exercise (M): 141,587 · Sale (S): 76,969 @ $1.53 · Option exercise (M): 141,587 (derivative) @ $0EDGAR
2023-08-184PRECIGEN, INC. (PGEN)Option exercise (M): 141,587 · Sale (S): 55,855 @ $1.66 · Option exercise (M): 141,587 (derivative) @ $0EDGAR
2023-08-114PRECIGEN, INC. (PGEN)Option exercise (M): 141,587 · Sale (S): 41,436 @ $1.44 · Option exercise (M): 141,587 (derivative) @ $0EDGAR
2023-08-044PRECIGEN, INC. (PGEN)Option exercise (M): 141,587 · Sale (S): 52,870 @ $1.10 · Option exercise (M): 141,587 (derivative) @ $0EDGAR
2023-06-134Kinnate Biopharma Inc. (KNTE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-024PRECIGEN, INC. (PGEN)Grant/award (A): 1,732,300 (derivative) @ $0EDGAR
2023-03-284PRECIGEN, INC. (PGEN)Option exercise (M): 283,173 · Grant/award (A): 849,520 (derivative) @ $0 · Option exercise (M): 283,173 (derivative) @ $0 · Grant/award (A): 369,596 (derivative) @ $0EDGAR
2023-01-304PRECIGEN, INC. (PGEN)Purchase (P): 22,857 @ $1.75EDGAR
2023-01-064PRECIGEN, INC. (PGEN)Option exercise (M): 17,665 · Option exercise (M): 17,665 (derivative) @ $0EDGAR
2022-06-154Kinnate Biopharma Inc. (KNTE)Grant/award (A): 20,250 (derivative) @ $0EDGAR
2022-05-164PRECIGEN, INC. (PGEN)Option exercise (M): 340,909 · Sale (S): 177,968 @ $1.19 · Option exercise (M): 340,909 (derivative) @ $0EDGAR
2022-03-224PRECIGEN, INC. (PGEN)Grant/award (A): 340,909 (derivative) @ $0EDGAR
2022-02-044PRECIGEN, INC. (PGEN)Grant/award (A): 847,000 (derivative) @ $0EDGAR
2022-01-064PRECIGEN, INC. (PGEN)Option exercise (M): 17,667 · Sale (S): 1,357 @ $3.59 · Sale (S): 5,603 @ $3.59 · Option exercise (M): 17,667 (derivative) @ $0EDGAR
2022-01-044PRECIGEN, INC. (PGEN)Option exercise (M): 9,765 · Sale (S): 3,848 @ $3.67 · Option exercise (M): 9,765 (derivative) @ $0EDGAR
2021-07-204PRECIGEN, INC. (PGEN)Option exercise (M): 25,000 · Sale (S): 12,531 @ $5.43 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-06-284Kinnate Biopharma Inc. (KNTE)Grant/award (A): 40,501 (derivative) @ $0EDGAR
2021-05-144PRECIGEN, INC. (PGEN)Option exercise (M): 97,276 · Sale (S): 47,433 @ $6.40 · Option exercise (M): 97,276 (derivative) @ $0EDGAR
2021-03-294PRECIGEN, INC. (PGEN)Grant/award (A): 97,276 (derivative) @ $0EDGAR
2021-01-074PRECIGEN, INC. (PGEN)Option exercise (M): 500,000 · Sale (S): 260,045 @ $8.92 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2021-01-064PRECIGEN, INC. (PGEN)Option exercise (M): 17,667 · Sale (S): 9,040 @ $10.56 · Option exercise (M): 17,667 (derivative) @ $0EDGAR
2021-01-054PRECIGEN, INC. (PGEN)Option exercise (M): 9,766 · Sale (S): 5,279 @ $10.16 · Option exercise (M): 9,766 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724195 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs